Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Christian Hansen Holding    CHR   DK0060227585

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Chr. Hansen Holding : Announcements from Financière Star 1 S.A. and Novo A/S in accordance with Section 29 of the Danish Securities Trading Act

share with twitter share with LinkedIn share with facebook
share via e-mail
03/29/2012 | 01:14pm CET

Hoersholm, 2012-03-29 11:38 CEST (GLOBE NEWSWIRE) --  

Company announcement no.12/2012

Today Chr. Hansen Holding A/S has received major shareholder announcements from Financière Star 1 S.A. and Novo A/S.

According to the announcement from Financière Star 1 S.A., Financière Star 1 S.A. today has sold 35,419,331 shares in Chr. Hansen Holding A/S thus reducing its holdings of shares in Chr. Hansen Holding A/S to 129,442 shares (corresponding to 0.09% of the share capital and voting rights).

According to the announcement from Novo A/S, Novo A/S today has acquired 35,419,331 Chr. Hansen Holding A/S shares and now holds 35,419,331 shares in Chr. Hansen Holding A/S (corresponding to 25.66% of the share capital and voting rights).

The above changes are due to the completion of the share purchase agreement between Financière Star 1 S.A. and Novo A/S announced in company announcement no. 02/2012 of 11 January 2012.

For further information, please contact:

Anders Mohr Christensen, Head of Investor Relations

Tel: +45 4574 7618

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2010/11 financial year was EUR 636 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,300 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.www.chr-hansen.com.

distributed by

This press release was issued by Chr. Hansen Holding A/S and was initially posted at http://investor.chr-hansen.com/releasedetail.cfm?ReleaseID=660271 . It was distributed, unedited and unaltered, by noodls on 2012-03-29 13:06:51 PM. The issuer is solely responsible for the accuracy of the information contained therein.

share with twitter share with LinkedIn share with facebook
share via e-mail
11/30 CHRISTIAN HANSEN : ​Chr. Hansen enters into partnership with Rheolution In..
11/29 CHRISTIAN HANSEN HOLDING : ex-dividend day for annual dividend
11/28 Wind turbine makers and Shell lift European shares
11/28 CHRISTIAN HANSEN : ​Cees de Jong will step down as CEO of Chr. Hansen Hold..
11/28 CHRISTIAN HANSEN : Cees de Jong will step down as CEO of Chr. Hansen Holding A/S
11/24 CHRISTIAN HANSEN : A new generation of yellow and orange beverage colors by Chr...
11/07 PROBIOTIC DAIRY PRODUCTS FOR CHILDRE : An untapped market with global appeal
11/06 CHRISTIAN HANSEN : Introducing a new range of oil soluble coloring foodstuffs; F..
11/02 CHRISTIAN HANSEN : Better bioprotection for more dairy products in more regions
11/01 ​SUSTAINABLE REVENUE : 81% supports UN Global Goals
More news
Financials (€)
Sales 2018 1 136 M
EBIT 2018 331 M
Net income 2018 243 M
Debt 2018 593 M
Yield 2018 1,60%
P/E ratio 2018 40,79
P/E ratio 2019 35,91
EV / Sales 2018 9,14x
EV / Sales 2019 8,31x
Capitalization 9 790 M
Duration : Period :
Christian Hansen Holding Technical Analysis Chart | CHR | DK0060227585 | 4-Traders
Technical analysis trends CHRISTIAN HANSEN HOLDING
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 16
Average target price 68,9 €
Spread / Average Target -7,2%
EPS Revisions
Cees de Jong President & Chief Executive Officer
Ole Gjessø Andersen Chairman
Søren Westh Lonning Chief Financial Officer & Executive Vice President
Thomas Schäfer Chief Scientific Officer & Executive VP
Frédéric P. Stévenin Independent Director
Sector and Competitors